Founded in April 2010, HistoIndex® is a MedTech spin-off company from the Institute of Biotechnology and Nanotechnology (IBN), Agency of Science, Technology and Research (A*STAR), Singapore. We are involved in the research & development, manufacturing and distribution of optical medical imaging equipment, as well as in the provision of related services, to aid pathologists in diagnostics for fibrosis and cancer. Our focus is on the accurate assessment of nonalcoholic steatohepatitis (NASH), a silent chronic liver disease that is linked to unhealthy lifestyles and metabolic syndromes. NASH faces a huge unmet medical need in our world today, and is expected to become the biggest cause of liver transplants by 2020. Our imaging systems, Genesis - which function on Second Harmonic Generation (SHG) and Two-Photon Excitation (TPE) - have opened doors towards new medical standards that benefit clinical research, accelerate pharmaceutical drug development and enhance clinical diagnostics for NASH and other chronic conditions.
Founded in April 2010, HistoIndex® is a MedTech spin-off company from the Institute of Biotechnology and Nanotechnology (IBN), Agency of Science, Technology and Research (A*STAR), Singapore. We are involved in the research & development, manufacturing and distribution of optical medical imaging equipment, as well as in the provision of related services, to aid pathologists in diagnostics for fibrosis and cancer. Our focus is on the accurate assessment of nonalcoholic steatohepatitis (NASH), a silent chronic liver disease that is linked to unhealthy lifestyles and metabolic syndromes. NASH faces a huge unmet medical need in our world today, and is expected to become the biggest cause of liver transplants by 2020. Our imaging systems, Genesis - which function on Second Harmonic Generation (SHG) and Two-Photon Excitation (TPE) - have opened doors towards new medical standards that benefit clinical research, accelerate pharmaceutical drug development and enhance clinical diagnostics for NASH and other chronic conditions.
Founded in April 2010, HistoIndex® is a MedTech spin-off company from the Institute of Biotechnology and Nanotechnology (IBN), Agency of Science, Technology and Research (A*STAR), Singapore. We are involved in the research & development, manufacturing and distribution of optical medical imaging equipment, as well as in the provision of related services, to aid pathologists in diagnostics for fibrosis and cancer. Our focus is on the accurate assessment of nonalcoholic steatohepatitis (NASH), a silent chronic liver disease that is linked to unhealthy lifestyles and metabolic syndromes. NASH faces a huge unmet medical need in our world today, and is expected to become the biggest cause of liver transplants by 2020. Our imaging systems, Genesis - which function on Second Harmonic Generation (SHG) and Two-Photon Excitation (TPE) - have opened doors towards new medical standards that benefit clinical research, accelerate pharmaceutical drug development and enhance clinical diagnostics for NASH and other chronic conditions.